Published in Proc Natl Acad Sci U S A on May 22, 2009
Structure of a nanobody-stabilized active state of the β(2) adrenoceptor. Nature (2011) 9.61
Structure of an agonist-bound human A2A adenosine receptor. Science (2011) 6.21
Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation. Nature (2011) 4.60
The dynamic process of β(2)-adrenergic receptor activation. Cell (2013) 4.09
Structure-function of the G protein-coupled receptor superfamily. Annu Rev Pharmacol Toxicol (2012) 3.83
Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor. Nature (2010) 3.19
Biased signaling pathways in β2-adrenergic receptor characterized by 19F-NMR. Science (2012) 3.07
Conserved binding mode of human beta2 adrenergic receptor inverse agonists and antagonist revealed by X-ray crystallography. J Am Chem Soc (2010) 2.62
Stabilized G protein binding site in the structure of constitutively active metarhodopsin-II. Proc Natl Acad Sci U S A (2011) 1.96
Ligand-regulated oligomerization of beta(2)-adrenoceptors in a model lipid bilayer. EMBO J (2009) 1.86
Ligand-specific interactions modulate kinetic, energetic, and mechanical properties of the human β2 adrenergic receptor. Structure (2012) 1.85
G-protein-coupled receptor inactivation by an allosteric inverse-agonist antibody. Nature (2012) 1.82
Nanobody stabilization of G protein-coupled receptor conformational states. Curr Opin Struct Biol (2011) 1.75
Monomeric rhodopsin is sufficient for normal rhodopsin kinase (GRK1) phosphorylation and arrestin-1 binding. J Biol Chem (2010) 1.66
Ligand-dependent perturbation of the conformational ensemble for the GPCR β2 adrenergic receptor revealed by HDX. Structure (2011) 1.54
The role of ligands on the equilibria between functional states of a G protein-coupled receptor. J Am Chem Soc (2013) 1.48
Recent developments in biased agonism. Curr Opin Cell Biol (2013) 1.44
Structural insights into adrenergic receptor function and pharmacology. Trends Pharmacol Sci (2011) 1.42
Allosteric sodium in class A GPCR signaling. Trends Biochem Sci (2014) 1.41
Therapeutic antibodies directed at G protein-coupled receptors. MAbs (2010) 1.41
Ligand-directed signalling at beta-adrenoceptors. Br J Pharmacol (2010) 1.40
Efficacy of the β₂-adrenergic receptor is determined by conformational equilibrium in the transmembrane region. Nat Commun (2012) 1.40
Inactive-state preassembly of G(q)-coupled receptors and G(q) heterotrimers. Nat Chem Biol (2011) 1.36
The structural basis of G-protein-coupled receptor signaling (Nobel Lecture). Angew Chem Int Ed Engl (2013) 1.25
New insights into the mechanisms whereby low molecular weight CCR5 ligands inhibit HIV-1 infection. J Biol Chem (2010) 1.16
The role of protein dynamics in GPCR function: insights from the β2AR and rhodopsin. Curr Opin Cell Biol (2014) 1.13
Ligands and signaling proteins govern the conformational landscape explored by a G protein-coupled receptor. Proc Natl Acad Sci U S A (2012) 1.12
Recent progress on the identification of metabotropic glutamate 4 receptor ligands and their potential utility as CNS therapeutics. ACS Chem Neurosci (2011) 1.10
Modulation of the interaction between neurotensin receptor NTS1 and Gq protein by lipid. J Mol Biol (2012) 1.10
Role of detergents in conformational exchange of a G protein-coupled receptor. J Biol Chem (2012) 1.10
Multiple CCR5 conformations on the cell surface are used differentially by human immunodeficiency viruses resistant or sensitive to CCR5 inhibitors. J Virol (2011) 1.07
Conformational dynamics of single G protein-coupled receptors in solution. J Phys Chem B (2011) 1.06
Allosteric regulation of G protein-coupled receptor activity by phospholipids. Nat Chem Biol (2015) 1.06
Detection of G protein-selective G protein-coupled receptor (GPCR) conformations in live cells. J Biol Chem (2013) 1.05
Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs. Nat Commun (2014) 1.05
A key agonist-induced conformational change in the cannabinoid receptor CB1 is blocked by the allosteric ligand Org 27569. J Biol Chem (2012) 1.04
Illuminating the activation mechanisms and allosteric properties of metabotropic glutamate receptors. Proc Natl Acad Sci U S A (2013) 1.04
Fulfilling the Promise of "Biased" G Protein-Coupled Receptor Agonism. Mol Pharmacol (2015) 1.01
Predicting novel binding modes of agonists to β adrenergic receptors using all-atom molecular dynamics simulations. PLoS Comput Biol (2011) 0.99
High constitutive activity is an intrinsic feature of ghrelin receptor protein: a study with a functional monomeric GHS-R1a receptor reconstituted in lipid discs. J Biol Chem (2011) 0.99
Conserved water-mediated hydrogen bond network between TM-I, -II, -VI, and -VII in 7TM receptor activation. J Biol Chem (2010) 0.99
Development and characterization of pepducins as Gs-biased allosteric agonists. J Biol Chem (2014) 0.98
Novel insights on thyroid-stimulating hormone receptor signal transduction. Endocr Rev (2013) 0.97
Biophysical characterization of membrane proteins in nanodiscs. Methods (2012) 0.96
Single-molecule view of basal activity and activation mechanisms of the G protein-coupled receptor β2AR. Proc Natl Acad Sci U S A (2015) 0.94
β₂-adrenergic receptor activation by agonists studied with ¹⁹F NMR spectroscopy. Angew Chem Int Ed Engl (2013) 0.92
Allosteric coupling from G protein to the agonist-binding pocket in GPCRs. Nature (2016) 0.92
Elliptical structure of phospholipid bilayer nanodiscs encapsulated by scaffold proteins: casting the roles of the lipids and the protein. J Am Chem Soc (2010) 0.90
A constitutively activating mutation alters the dynamics and energetics of a key conformational change in a ligand-free G protein-coupled receptor. J Biol Chem (2013) 0.89
Coupling of g proteins to reconstituted monomers and tetramers of the M2 muscarinic receptor. J Biol Chem (2014) 0.88
Use of G-protein-coupled and -uncoupled CCR5 receptors by CCR5 inhibitor-resistant and -sensitive human immunodeficiency virus type 1 variants. J Virol (2013) 0.87
Opportunities for functional selectivity in GPCR antibodies. Biochem Pharmacol (2012) 0.86
Single-molecule analysis of ligand efficacy in β2AR-G-protein activation. Nature (2017) 0.82
Stabilization of G protein-coupled receptors by point mutations. Front Pharmacol (2015) 0.81
Structural Elements in the Gαs and Gαq C Termini That Mediate Selective G Protein-coupled Receptor (GPCR) Signaling. J Biol Chem (2016) 0.81
Communication over the network of binary switches regulates the activation of A2A adenosine receptor. PLoS Comput Biol (2015) 0.80
Stability of the neurotensin receptor NTS1 free in detergent solution and immobilized to affinity resin. PLoS One (2010) 0.80
Structure-function studies with G protein-coupled receptors as a paradigm for improving drug discovery and development of therapeutics. Biotechnol J (2012) 0.80
Agonism, Antagonism, and Inverse Agonism Bias at the Ghrelin Receptor Signaling. J Biol Chem (2015) 0.79
Transmembrane signal transduction by peptide hormones via family B G protein-coupled receptors. Front Pharmacol (2015) 0.78
Cell-free translation and purification of Arabidopsis thaliana regulator of G signaling 1 protein. Protein Expr Purif (2016) 0.78
Allosteric Activation of a G Protein-coupled Receptor with Cell-penetrating Receptor Mimetics. J Biol Chem (2015) 0.77
Advances in receptor conformation research: the quest for functionally selective conformations focusing on the β2 -adrenoceptor. Br J Pharmacol (2015) 0.76
Sensing conformational changes in metabotropic glutamate receptors. Proc Natl Acad Sci U S A (2013) 0.76
Peptide ligand recognition by G protein-coupled receptors. Front Pharmacol (2015) 0.76
Mechanistic insights into GPCR-G protein interactions. Curr Opin Struct Biol (2016) 0.75
Comparative MD Simulations Indicate a Dual Role for Arg1323.50 in Dopamine-Dependent D2R Activation. PLoS One (2016) 0.75
Allosteric communication pipelines in G-protein-coupled receptors. Curr Opin Pharmacol (2016) 0.75
β-arrestin-biased signaling through the β2-adrenergic receptor promotes cardiomyocyte contraction. Proc Natl Acad Sci U S A (2016) 0.75
Disulfide mapping the voltage-sensing mechanism of a voltage-dependent potassium channel. Sci Rep (2016) 0.75
Priming GPCR signaling through the synergistic effect of two G proteins. Proc Natl Acad Sci U S A (2017) 0.75
Regulation of P450-mediated permethrin resistance in Culex quinquefasciatus by the GPCR/Gαs/AC/cAMP/PKA signaling cascade. Biochem Biophys Rep (2017) 0.75
G protein stoichiometry dictates biased agonism through distinct receptor-G protein partitioning. Sci Rep (2017) 0.75
New approaches towards the understanding of integral membrane proteins - A structural perspective on G protein-coupled receptors. Protein Sci (2017) 0.75
Crystal structure of rhodopsin: A G protein-coupled receptor. Science (2000) 28.60
High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science (2007) 20.32
Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature (2007) 14.06
Structure of a beta1-adrenergic G-protein-coupled receptor. Nature (2008) 11.97
GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function. Science (2007) 11.74
The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science (2008) 11.74
Transduction of receptor signals by beta-arrestins. Science (2005) 9.87
CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues. Nucleic Acids Res (2006) 9.19
Crystal structure of opsin in its G-protein-interacting conformation. Nature (2008) 8.61
The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure. J Mol Biol (2004) 7.38
Crystal structure of the ligand-free G-protein-coupled receptor opsin. Nature (2008) 7.20
Structure of bovine rhodopsin in a trigonal crystal form. J Mol Biol (2004) 6.80
A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. J Biol Chem (1980) 6.06
A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein. Proc Natl Acad Sci U S A (2007) 6.04
High-resolution distance mapping in rhodopsin reveals the pattern of helix movement due to activation. Proc Natl Acad Sci U S A (2008) 5.06
The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J Cell Sci (2002) 5.04
Crystal structure of squid rhodopsin. Nature (2008) 4.58
Functional role of internal water molecules in rhodopsin revealed by X-ray crystallography. Proc Natl Acad Sci U S A (2002) 4.12
A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling. Proc Natl Acad Sci U S A (2007) 3.82
Coupling ligand structure to specific conformational switches in the beta2-adrenoceptor. Nat Chem Biol (2006) 3.76
Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Proc Natl Acad Sci U S A (2003) 3.75
GTPase mechanism of Gproteins from the 1.7-A crystal structure of transducin alpha-GDP-AIF-4. Nature (1994) 3.66
Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs). Biochemistry (2001) 3.62
Activation of the beta 2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. J Biol Chem (2001) 3.49
Functionally different agonists induce distinct conformations in the G protein coupling domain of the beta 2 adrenergic receptor. J Biol Chem (2001) 3.41
Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the beta 2-adrenoceptor. Nature (1995) 3.27
Relationship between the beta-adrenergic receptor and adenylate cyclase. J Biol Chem (1977) 2.99
Real-time monitoring of receptor and G-protein interactions in living cells. Nat Methods (2005) 2.72
Sequential binding of agonists to the beta2 adrenoceptor. Kinetic evidence for intermediate conformational states. J Biol Chem (2003) 2.68
Crystal structure of the adenylyl cyclase activator Gsalpha. Science (1997) 2.68
Probing the beta2 adrenoceptor binding site with catechol reveals differences in binding and activation by agonists and partial agonists. J Biol Chem (2005) 2.64
Purification of recombinant G proteins from Sf9 cells by hexahistidine tagging of associated subunits. Characterization of alpha 12 and inhibition of adenylyl cyclase by alpha z. J Biol Chem (1995) 2.61
Agonist-induced conformational changes in the G-protein-coupling domain of the beta 2 adrenergic receptor. Proc Natl Acad Sci U S A (2001) 2.58
Agonists induce conformational changes in transmembrane domains III and VI of the beta2 adrenoceptor. EMBO J (1997) 2.26
Inverse agonist activity of beta-adrenergic antagonists. Mol Pharmacol (1994) 2.22
Dynamics of receptor/G protein coupling in living cells. EMBO J (2005) 2.06
Heterotrimeric G proteins precouple with G protein-coupled receptors in living cells. Proc Natl Acad Sci U S A (2005) 1.91
X-Ray diffraction analysis of three-dimensional crystals of bovine rhodopsin obtained from mixed micelles. J Struct Biol (2000) 1.88
Structure and conformational changes in the C-terminal domain of the beta2-adrenoceptor: insights from fluorescence resonance energy transfer studies. J Biol Chem (2007) 1.85
Negative antagonists promote an inactive conformation of the beta 2-adrenergic receptor. Mol Pharmacol (1994) 1.83
Molecular basis of inverse agonism in a G protein-coupled receptor. Nat Chem Biol (2005) 1.60
Agonist-induced conformational changes at the cytoplasmic side of transmembrane segment 6 in the beta 2 adrenergic receptor mapped by site-selective fluorescent labeling. J Biol Chem (2000) 1.49
Crystal structure of squid rhodopsin with intracellularly extended cytoplasmic region. J Biol Chem (2008) 1.48
A new approach to producing functional G alpha subunits yields the activated and deactivated structures of G alpha(12/13) proteins. Biochemistry (2006) 1.27
Different effects of Gsalpha splice variants on beta2-adrenoreceptor-mediated signaling. The beta2-adrenoreceptor coupled to the long splice variant of Gsalpha has properties of a constitutively active receptor. J Biol Chem (1998) 1.25
Absolute requirement for GTP in activation of human neutrophil NADPH oxidase in a cell-free system: role of ATP in regenerating GTP. Proc Natl Acad Sci U S A (1992) 1.00
Allosteric effects of G protein overexpression on the binding of beta-adrenergic ligands with distinct inverse efficacies. Mol Pharmacol (2001) 0.96
Pharmacological onomastics: what's in a name? Br J Pharmacol (2007) 0.95
Origin of guanine nucleotides in isolated heart mitochondria. Biochem Biophys Res Commun (1999) 0.92
High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science (2007) 20.32
Crystal structure of the β2 adrenergic receptor-Gs protein complex. Nature (2011) 13.92
GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function. Science (2007) 11.74
Structure of a nanobody-stabilized active state of the β(2) adrenoceptor. Nature (2011) 9.61
The structure and function of G-protein-coupled receptors. Nature (2009) 8.08
Functional selectivity and classical concepts of quantitative pharmacology. J Pharmacol Exp Ther (2006) 7.03
Crystal structure of the µ-opioid receptor bound to a morphinan antagonist. Nature (2012) 6.18
A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein. Proc Natl Acad Sci U S A (2007) 6.04
Structure and function of an irreversible agonist-β(2) adrenoceptor complex. Nature (2011) 5.35
Molecular signatures of G-protein-coupled receptors. Nature (2013) 5.19
Conformational complexity of G-protein-coupled receptors. Trends Pharmacol Sci (2007) 5.18
Coupling ligand structure to specific conformational switches in the beta2-adrenoceptor. Nat Chem Biol (2006) 3.76
Conformational biosensors reveal GPCR signalling from endosomes. Nature (2013) 3.29
Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor. Nature (2010) 3.19
Maltose-neopentyl glycol (MNG) amphiphiles for solubilization, stabilization and crystallization of membrane proteins. Nat Methods (2010) 2.77
Probing the beta2 adrenoceptor binding site with catechol reveals differences in binding and activation by agonists and partial agonists. J Biol Chem (2005) 2.64
Efficient coupling of transducin to monomeric rhodopsin in a phospholipid bilayer. J Biol Chem (2007) 2.59
Conformational changes in the G protein Gs induced by the β2 adrenergic receptor. Nature (2011) 2.43
Caveolar localization dictates physiologic signaling of beta 2-adrenoceptors in neonatal cardiac myocytes. J Biol Chem (2002) 2.06
Structural flexibility of the G alpha s alpha-helical domain in the beta2-adrenoceptor Gs complex. Proc Natl Acad Sci U S A (2011) 2.03
Ligand-regulated oligomerization of beta(2)-adrenoceptors in a model lipid bilayer. EMBO J (2009) 1.86
Structure and conformational changes in the C-terminal domain of the beta2-adrenoceptor: insights from fluorescence resonance energy transfer studies. J Biol Chem (2007) 1.85
Tracking G-protein-coupled receptor activation using genetically encoded infrared probes. Nature (2010) 1.79
Identification of small-molecule inhibitors of RGS4 using a high-throughput flow cytometry protein interaction assay. Mol Pharmacol (2006) 1.78
A bacterial cocaine esterase protects against cocaine-induced epileptogenic activity and lethality. Ann Emerg Med (2008) 1.77
Rapid and robust protection against cocaine-induced lethality in rats by the bacterial cocaine esterase. Mol Pharmacol (2006) 1.66
Phosphodiesterase 4D is required for beta2 adrenoceptor subtype-specific signaling in cardiac myocytes. Proc Natl Acad Sci U S A (2005) 1.65
Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol Pharmacol (2008) 1.60
A monoclonal antibody for G protein-coupled receptor crystallography. Nat Methods (2007) 1.60
Purification and functional reconstitution of monomeric mu-opioid receptors: allosteric modulation of agonist binding by Gi2. J Biol Chem (2009) 1.59
Structural insights into biased G protein-coupled receptor signaling revealed by fluorescence spectroscopy. Proc Natl Acad Sci U S A (2012) 1.57
Cocaine esterase: interactions with cocaine and immune responses in mice. J Pharmacol Exp Ther (2006) 1.55
Signaling from beta1- and beta2-adrenergic receptors is defined by differential interactions with PDE4. EMBO J (2008) 1.50
Using synthetic lipids to stabilize purified beta2 adrenoceptor in detergent micelles. Anal Biochem (2005) 1.49
The role of internal water molecules in the structure and function of the rhodopsin family of G protein-coupled receptors. Chembiochem (2007) 1.47
A new era of GPCR structural and chemical biology. Nat Chem Biol (2012) 1.41
SUMO modification regulates inactivation of the voltage-gated potassium channel Kv1.5. Proc Natl Acad Sci U S A (2007) 1.39
N-terminal residues control proteasomal degradation of RGS2, RGS4, and RGS5 in human embryonic kidney 293 cells. Mol Pharmacol (2007) 1.35
Mass spectrometric analysis of agonist effects on posttranslational modifications of the beta-2 adrenoceptor in mammalian cells. Biochemistry (2005) 1.34
Plasmon-waveguide resonance studies of ligand binding to the human beta 2-adrenergic receptor. Biochemistry (2004) 1.32
The PDZ-binding motif of the beta2-adrenoceptor is essential for physiologic signaling and trafficking in cardiac myocytes. Proc Natl Acad Sci U S A (2003) 1.32
Chemical and functional analysis of hydroxyurea oral solutions. J Pediatr Hematol Oncol (2004) 1.30
Protecting the myocardium: a role for the beta2 adrenergic receptor in the heart. Crit Care Med (2004) 1.28
Visualization of dopamine transporter trafficking in live neurons by use of fluorescent cocaine analogs. J Neurosci (2009) 1.26
Allosteric modulation of beta2-adrenergic receptor by Zn(2+). Mol Pharmacol (2002) 1.25
Differentially regulated expression of endogenous RGS4 and RGS7. J Biol Chem (2003) 1.25
Activation of G protein-coupled receptors. Adv Protein Chem (2007) 1.20
Cocaine esterase prevents cocaine-induced toxicity and the ongoing intravenous self-administration of cocaine in rats. J Pharmacol Exp Ther (2009) 1.19
The hsp90 cochaperone p23 is the limiting component of the multiprotein hsp90/hsp70-based chaperone system in vivo where it acts to stabilize the client protein: hsp90 complex. J Biol Chem (2003) 1.18
Nitric oxide-dependent allosteric inhibitory role of a second nucleotide binding site in soluble guanylyl cyclase. J Biol Chem (2005) 1.15
The PDZ binding motif of the beta 1 adrenergic receptor modulates receptor trafficking and signaling in cardiac myocytes. J Biol Chem (2002) 1.15
A structural insight into the reorientation of transmembrane domains 3 and 5 during family A G protein-coupled receptor activation. Mol Pharmacol (2010) 1.14
Activation of CCR5 by chemokines involves an aromatic cluster between transmembrane helices 2 and 3. J Biol Chem (2002) 1.13
A thermally stable form of bacterial cocaine esterase: a potential therapeutic agent for treatment of cocaine abuse. Mol Pharmacol (2010) 1.12
Abnormal cardiac function associated with sympathetic nervous system hyperactivity in mice. Am J Physiol Heart Circ Physiol (2002) 1.12
Real-time detection of basal and stimulated G protein GTPase activity using fluorescent GTP analogues. J Biol Chem (2004) 1.12
Structural analysis of thermostabilizing mutations of cocaine esterase. Protein Eng Des Sel (2010) 1.10
Cholesterol increases kinetic, energetic, and mechanical stability of the human β2-adrenergic receptor. Proc Natl Acad Sci U S A (2012) 1.09
Mechanism of action and structural requirements of constrained peptide inhibitors of RGS proteins. Chem Biol Drug Des (2006) 1.08
Rhodamine-labeled 2beta-carbomethoxy-3beta-(3,4-dichlorophenyl)tropane analogues as high-affinity fluorescent probes for the dopamine transporter. J Med Chem (2005) 1.07
Prevention and reversal by cocaine esterase of cocaine-induced cardiovascular effects in rats. Drug Alcohol Depend (2009) 1.07
Molecular basis of ligand dissociation in β-adrenergic receptors. PLoS One (2011) 1.06
Long-lasting effects of a PEGylated mutant cocaine esterase (CocE) on the reinforcing and discriminative stimulus effects of cocaine in rats. Neuropsychopharmacology (2011) 1.06
Tandem facial amphiphiles for membrane protein stabilization. J Am Chem Soc (2010) 1.05
Detection of G protein-selective G protein-coupled receptor (GPCR) conformations in live cells. J Biol Chem (2013) 1.05
Regulation of cytochrome P450 2E1 by heat shock protein 90-dependent stabilization and CHIP-dependent proteasomal degradation. Biochemistry (2005) 1.04
Influence of the environment in the conformation of alpha-helices studied by protein database search and molecular dynamics simulations. Biophys J (2002) 1.01
Amelioration of the cardiovascular effects of cocaine in rhesus monkeys by a long-acting mutant form of cocaine esterase. Neuropsychopharmacology (2011) 0.98
Effects of cocaine esterase following its repeated administration with cocaine in mice. Drug Alcohol Depend (2009) 0.97
A new class of amphiphiles bearing rigid hydrophobic groups for solubilization and stabilization of membrane proteins. Chemistry (2012) 0.96
Proerectile effects of dopamine D2-like agonists are mediated by the D3 receptor in rats and mice. J Pharmacol Exp Ther (2009) 0.96
ARF6 activation by Galpha q signaling: Galpha q forms molecular complexes with ARNO and ARF6. Cell Signal (2006) 0.95
Insights into congenital stationary night blindness based on the structure of G90D rhodopsin. EMBO Rep (2013) 0.95
Structural basis for activation of G-protein-coupled receptors. Pharmacol Toxicol (2002) 0.95
Toward understanding GPCR dimers. Nat Struct Mol Biol (2004) 0.93
Glucose-neopentyl glycol (GNG) amphiphiles for membrane protein study. Chem Commun (Camb) (2013) 0.93
Relation between sequence and structure in membrane proteins. Bioinformatics (2013) 0.92
Regulation of G-protein coupled receptor traffic by an evolutionary conserved hydrophobic signal. Traffic (2010) 0.92
Allosteric coupling from G protein to the agonist-binding pocket in GPCRs. Nature (2016) 0.92